Early phase clinical trial units (epctu)
Active Awarded Last action
- Contract number
- 75N93022D00015
- Awardee
-
Allucent Government Services (Us) LLC UEI C7DJDL6EZT94
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Task orders
- 2 $3,755,767 obligated
Award facts
- Opportunity
-
- Early Phase Clinical Trial Units (EPCTU) Pre-Solicitation · 75N93020R00023 · Posted Nov 19, 2020
- Combined order value
-
- $3,755,767 Current, with exercised options
- $4,713,793 Potential, with all options
- Last date to order 48% complete
- IDV ceiling 1% used
- $346,610,277.00
- Award type
- Multiple award
- Who can order
- Only the awarding agency
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 6 offers Negotiated Proposal / Quote
- Pricing
- Cost Plus Fixed Fee
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
About this IDV
The National Institute of Allergy and Infectious Diseases awarded a multiple-award indefinite-delivery contract to Allucent Government Services (Us) LLC on January 14, 2022, with a ceiling of $346.6 million and ultimate completion date of January 13, 2032. This is an Early Phase Clinical Trial Units (EPCTU) contract supporting Phase 0 through Phase III clinical trials for investigational infectious disease products. Place of performance includes Houston, Texas and Cary, North Carolina. The contract uses cost-plus-fixed-fee pricing with no set-aside designation. NAICS codes 541715 and 541712 and PSC codes R425 and R499 apply.
Allucent will provide clinical trial planning and execution, administrative and operational support, concept development, regulatory support, and specimen collection and management to advance NIAID's infectious disease research objectives. The seven-year ordering period began January 2022. Two task orders have been issued under this IDIQ: Task Order 75N93022F00001 (base award, January 14, 2022, $1.5 million ceiling, Houston, Texas, through January 13, 2032) supports administrative and overall clinical operations support and concept development; Task Order 75N93024F00001 (August 15, 2024, $3.2 million ceiling, Cary, North Carolina, through May 14, 2027) supports clinical trial execution.
Task orders
| Task order | Ordering agency | Obligated | Awarded |
|---|---|---|---|
| Task order 75N93024F00001 base award. | National Institute of Allergy and Infectious Diseases (NIH) | $3,205,231 | |
| Task order 75N93022F00001 base award | National Institute of Allergy and Infectious Diseases (NIH) | $550,536 |
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Vendor DUNS or Name Change - Non-Novation | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Original award | $0 |
Quick answers
Who was awarded contract 75N93022D00015?
75N93022D00015 was awarded to Allucent Government Services (Us) LLC by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on January 14, 2022.
How much is contract 75N93022D00015 worth?
Orders under 75N93022D00015 have obligated $3,755,767. Their combined potential value, with all options, is $4,713,793. 75N93022D00015's own ceiling is $346,610,277.
How many orders have been placed under contract 75N93022D00015?
2 orders have been placed under 75N93022D00015, the latest on August 15, 2024.
Who can order from contract 75N93022D00015?
75N93022D00015 is a multiple award indefinite delivery contract. Only the awarding agency can place orders on it.
Is contract 75N93022D00015 part of a contract vehicle?
Yes. 75N93022D00015 is part of Early Phase Clinical Trial Units (EPCTU).
Was contract 75N93022D00015 competed?
The extent of competition for 75N93022D00015 was full and open competition. The government received 6 offers.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV